Form 4: Health Catalyst Director Julie Larson-Green Reports Acquisition of 2,450 Shares of Common Stock

Julie Larson-Green, a director at Health Catalyst, Inc., reported acquiring 2,450 shares of common stock on March 1, 2025, through the vesting of restricted stock units.

Summary

• On March 4, 2025, a Form 4 filing was submitted to the SEC by Julie Larson-Green, a director of Health Catalyst, Inc.
• The report details a transaction that occurred on March 1, 2025, where Ms. Larson-Green acquired 2,450 shares of Health Catalyst's common stock.
• This acquisition was due to the vesting of restricted stock units (RSUs) granted under the company's 2019 Stock Option and Incentive Plan.
• The RSUs vested on March 1, 2025, according to the terms of the Issuer's Non-Employee Director Compensation Policy.
• Following the reported transaction, Ms. Larson-Green beneficially owns 71,254 shares of Health Catalyst's common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction related to director compensation. There is no indication of positive or negative implications for the company's performance.

Positives

• The vesting of RSUs indicates that Ms. Larson-Green has met the conditions set by the company for receiving these shares.
• Increased ownership aligns the director's interests with those of other shareholders.

Industry Context

This filing is a routine disclosure related to insider transactions and is a common occurrence for publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine part of director compensation.

Key Dates